Vitamin K1 to slow vascular calcification in haemodialysis patients (VitaVasK trial): A rationale and study protocol

Nephrology Dialysis Transplantation

Volumn 29, Issue 9, 2014, Pages 1633-1638

  Krueger, Thilo ^a   Schlieper, Georg ^a   Schurgers, Leon ^b   Cornelis, Tom ^c   Cozzolino, Mario ^d   Jacobi, Johannes ^e   Jadoul, Michel ^f   Ketteler, Markus ^g   Rump, Lars C ^h   Stenvinkel, Peter ⁱ   Westenfeld, Ralf ^h   Wiecek, Andrzej ^j   Reinartz, Sebastian ^a   Hilgers, Ralf Dieter ^k   Floege, Jürgen ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF MILAN   (Italy)

^e UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^f CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^g KLINIKUM COBURG   (Germany)

^h UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

ⁱ KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^j MEDICAL UNIVERSITY OF SILESIA   (Poland)

^k RWTH AACHEN UNIVERSITY   (Germany)

more..

Author keywords

Haemodialysis; Matrix Gla protein; Vascular calcification; Vitamin K

Indexed keywords

KA VIT; MATRIX GLA PROTEIN; OSTEOCALCIN; PHYTOMENADIONE; PLACEBO; UNCLASSIFIED DRUG; ANTIFIBRINOLYTIC AGENT; CALCIUM BINDING PROTEIN; SCLEROPROTEIN;

ABSENCE OF SIDE EFFECTS; ADULT; AGATSTON SCORE; AORTA CALCIFICATION; AORTA VALVE DISEASE; ARTERY CALCIFICATION; BLOOD VESSEL CALCIFICATION; CARDIOVASCULAR DISEASE; CHEMOPROPHYLAXIS; CONTROLLED STUDY; CORONARY ARTERY CALCIFICATION; CORONARY ARTERY CALCIUM SCORE; COST EFFECTIVENESS ANALYSIS; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG COST; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HEART; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE DISEASE; MORTALITY; MULTICENTER STUDY; MULTIDETECTOR COMPUTED TOMOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECOMMENDED DRUG DOSE; REVIEW; RISK REDUCTION; SINGLE DRUG DOSE; STANDARD; THORACIC AORTA; TREATMENT DURATION; AORTIC VALVE CALCIFICATION; ARTICLE; MITRAL VALVE CALCIFICATION; MULTICENTER STUDY (TOPIC); OPEN STUDY; PARALLEL DESIGN; RANDOMIZED CONTROLLED TRIAL (TOPIC); THORACIC AORTIC CALCIFICATION; VITAMIN SUPPLEMENTATION; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY DISEASE; DISEASE COURSE; PATHOPHYSIOLOGY; PATIENT SELECTION; PHYSIOLOGY; PROSPECTIVE STUDY; RENAL REPLACEMENT THERAPY; VASCULAR CALCIFICATION;

ANTIFIBRINOLYTIC AGENTS; CALCIUM-BINDING PROTEINS; CORONARY ARTERY DISEASE; DISEASE PROGRESSION; EXTRACELLULAR MATRIX PROTEINS; HUMANS; MULTICENTER STUDIES AS TOPIC; PATIENT SELECTION; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RENAL DIALYSIS; TOMOGRAPHY, X-RAY COMPUTED; VASCULAR CALCIFICATION; VITAMIN K 1;

EID: 84907402723     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft459     Document Type: Review

References (28)

1. Kuzela DC, Huffer WE, Conger JD et al. Soft tissue calcification in chronic dialysis patients. Am J Pathol 1977; 86: 403-424
2. Blacher J, Guerin AP, Pannier B et al. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 2001; 38: 938-942
3. Doherty TM, Asotra K, Fitzpatrick LA et al . Calcification in atherosclerosis: bone biology and chronic inflammation at the arterial crossroads. Proc Natl Acad Sci USA 2003; 100: 11201-11206
4. Ketteler M, Bongartz P, Westenfeld R et al. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 2003; 361: 827-833
5. Schurgers LJ, Uitto J, Reutelingsperger CP. Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization. Trends Mol Med 2013; 19: 217-226
6. Luo G, Ducy P, McKee MD et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997; 386: 78-81
7. Koos R, Krueger T, Westenfeld R et al. Relation of circulating matrix Glaprotein and anticoagulation status in patients with aortic valve calcification. Thromb Haemost 2009; 101: 706-713
8. Holden RM, Sanfilippo AS, Hopman WM et al. Warfarin and aortic valve calcification in hemodialysis patients. J Nephrol 2007; 20: 417-422
9. Price PA, Faus SA, Williamson MK. Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves. Arterioscler Thromb Vasc Biol 1998; 18: 1400-1407
10. Wilmer WA, Magro CM. Calciphylaxis: emerging concepts in prevention, diagnosis, and treatment. Semin Dial 2002; 15: 172-186
11. Schurgers LJ, Spronk HM, Soute BA et al. Regression of warfarin-induced medial elastocalcinosis by high intake of vitamin K in rats. Blood 2007; 109: 2823-2831
12. Shea MK, O'Donnell CJ, Hoffmann U et al. Vitamin K supplementation and progression of coronary artery calcium in older men and women. Am J Clin Nutr 2009; 89: 1799-1807
13. Shea MK, O'Donnell CJ, Vermeer C et al. Circulating uncarboxylated matrix gla protein is associated with vitamin K nutritional status, but not coronary artery calcium, in older adults. J Nutr 2011; 141: 1529-1534
14. Cranenburg EC, Schurgers LJ, Uiterwijk HH et al. Vitamin K intake and status are low in hemodialysis patients. Kidney Int 2012; 82: 605-610
15. Holden RM, Morton AR, Garland JS et al. Vitamins K and D status in stages 3-5 chronic kidney disease. Clin J Am Soc Nephrol 2010; 5: 590-597
16. Westenfeld R, Krueger T, Schlieper G et al. Effect of vitamin K(2) supplementation on functional Vitamin K deficiency in hemodialysis patients: a randomized trial. Am J Kidney Dis 2012; 59: 186-195
17. von Kries R, Shearer M, McCarthy PT et al. Vitamin K1 content of maternal milk: influence of the stage of lactation, lipid composition, and vitamin K1 supplements given to the mother. Pediatr Res 1987; 22: 513-517
18. Theuwissen E, Cranenburg EC, Knapen MH et al. Low-dose menaquin-one-7 supplementation improved extra-hepatic vitamin K status, but had no effect on thrombin generation in healthy subjects. Br J Nutr 2012; 108: 1652-1657
19. Tsuchie H, Miyakoshi N, Hongo M et al. Amelioration of pregnancy-associated osteoporosis after treatment with vitamin K(2): a report of four patients. Ups J Med Sci 2012; 117: 336-341
20. Kumar R, Binkley N, Vella A. Effect of phylloquinone supplementation on glucose homeostasis in humans. Am J Clin Nutr 2010; 92: 1528-1532
21. Yoshida M, Jacques PF, Meigs JB et al. Effect of vitamin K supplementation on insulin resistance in older men and women. Diabetes Care 2008; 31: 2092-2096
22. Braam LA, Knapen MH, Geusens P et al. Vitamin K1 supplementation retards bone loss in postmenopausal women between 50 and 60 years of age. Calcif Tissue Int 2003; 73: 21-26
23. Schlieper G, Westenfeld R, Kruger T et al. Circulating nonphosphorylated carboxylated matrix Gla protein predicts survival in ESRD. J Am Soc Nephrol 2011; 22: 387-395
24. Pilkey RM, Morton AR, Boffa MB et al. Subclinical vitamin K deficiency in hemodialysis patients. Am J Kidney Dis 2007; 49: 432-439
25. Raggi P, Chertow GM, Torres PU et al. The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis. Nephrol Dial Transplant 2011; 26: 1327-1339
26. Callister TQ, Cooil B, Raya SP et al. Coronary artery disease: improved reproducibility of calcium scoring with an electron-beam CT volumetric method. Radiology 1998; 208: 807-814
27. Agatston AS, Janowitz WR, Hildner FJ et al. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990; 15: 827-832
28. Mazzaferro S, Pasquali M, Taggi F et al. Progression of coronary artery calcification in renal transplantation and the role of secondary hyperparathyroidism and inflammation. Clin J Am Soc Nephrol 2009; 4: 685-690